Skip to content

Nitrate-based Nutritional Formula for Oxygen Saturation and Patient-reported Outcomes in Covid-19

Short-term Intervention With Nitrate-based Nutritional Formula on Oxygen Saturation and Patient-reported Outcomes in Covid-19 Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05290298
Acronym
COVID-NITRA
Enrollment
52
Registered
2022-03-22
Start date
2021-09-01
Completion date
2022-02-15
Last updated
2022-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

A preliminary open-label case report demonstrated the beneficial effects of an innovative nitrate-based nutritional formula on oxygen saturation in patients with COVID-19. Whether these initial findings are relevant in a more robust research design currently remains unknown. Therefore, the main objective of this randomized controlled trial was to analyze the acute effects of nitrate-based nutritional formula on peripheral SpO2, patient-reported outcomes, and safety indices in patients with acute COVID-19 infection.

Interventions

DIETARY_SUPPLEMENTNITRATE

Multi-component nutritional formula

DIETARY_SUPPLEMENTPLACEBO

Placebo

Sponsors

University of Novi Sad, Faculty of Sport and Physical Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age 3 18 years * confirmed SARS-CoV-2 infection * SpO2 \< 95% * COVID-19 patients in stable condition (i.e., not requiring hospital admission)

Exclusion criteria

* regnant or lactating women * concomitant pulmonary and cardiovascular conditions * history of dietary supplement use during the past four weeks * participation in another COVID-19-related study * unwillingness to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in oxygen saturationBaseline vs. 72 hours post-interventionMeasured at baseline and 72 hours post-intervention

Secondary

MeasureTime frameDescription
Change in fatigueBaseline vs. 72 hours post-interventionMeasured at baseline and 72 hours post-intervention

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026